Zolpidem Tartrate
Rank #334 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$31.3M
Total Cost
3,144,599
Total Claims
$31.3M
Total Cost
71,452
Prescribers
$10
Cost per Claim
462,900
Beneficiaries
3,900,267
30-Day Fills
$438
Avg Cost/Provider
44
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$31.3M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $31.3M total
🔎 Data Overview
At $10.00 per prescription, this is an affordable generic medication. Wider use of affordable generics like this could save Medicare billions annually.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Zolpidem Tartrate
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Isabel Mendoza | Family Practice | Darlington, SC | 61 | $44K |
| 2 | Tatyana Tsipursky | Psychiatry | Brooklyn, NY | 61 | $43K |
| 3 | Fernando Taveras | Psychiatry | New York, NY | 33 | $23K |
| 4 | Charles Weber | Rheumatology | Wall Township, NJ | 34 | $23K |
| 5 | Isaac Snapp | Physician Assistant | Darlington, SC | 27 | $19K |
| 6 | Joshua Murphy | Nurse Practitioner | Lamar, SC | 27 | $18K |
| 7 | Allan Spiegel | Neurology | Palm Harbor, FL | 13 | $18K |
| 8 | Vikhta Gurevich | Psychiatry | Brooklyn, NY | 25 | $18K |
| 9 | Sherryl Rosen | Certified Clinical Nurse Specialist | Lynn, MA | 13 | $17K |
| 10 | Eva Khavkin | Psychiatry | Brooklyn, NY | 25 | $17K |
| 11 | Ellen Zagrebelsky | Geriatric Medicine | Philadelphia, PA | 25 | $17K |
| 12 | Inna Kigel | Family Practice | Kew Gardens, NY | 24 | $17K |
| 13 | Joseph Danial | Psychiatry | Abington, PA | 12 | $16K |
| 14 | Piyush Tiwari | Psychiatry | Honolulu, HI | 16 | $16K |
| 15 | Madeleine Heaney | Internal Medicine | Newtown Square, PA | 26 | $16K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 331 | Bumetanide (Bumetanide) | $32.4M | 735,077 |
| 332 | Voxelotor (Oxbryta) | $31.5M | 2,707 |
| 333 | Rivastigmine (Rivastigmine) | $31.4M | 118,567 |
| 334 | Zolpidem Tartrate (Zolpidem Tartrate) | $31.3M | 3,144,599 |
| 335 | Lorazepam (Lorazepam) | $31.3M | 3,237,827 |
| 336 | Diphth,pertuss(Acell),tet Vac (Boostrix Tdap) | $31.2M | 466,555 |
| 337 | Tafamidis Meglumine (Vyndaqel) | $31.0M | 1,387 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology